Treatment options in the management of choroidal metastases

Radgonde Amer, Jacob Pe'er*, Itay Chowers, Irene Anteby

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


We performed a retrospective study of 40 consecutive patients (50 eyes) treated for choroidal metastases of solid systemic malignancies in order to evaluate treatment results. Patients received either systemic or local therapy or a combination of both. The most common primary tumor was breast carcinoma (62.5%). Systemic chemotherapy alone was used in 13.3% of eyes, local therapy alone in 44.4%, and a combination of both in 42.2% of eyes. Local treatment modalities included brachytherapy, external beam irradiation, and laser photocoagulation. Complete regression of the choroidal metastases was seen in 57.8% of eyes, partial regression in 15.6 and no response in 4.4%; 22.2% were not available for reevaluation. We have concluded that the treatment modality in patients with metastatic ocular disease should be individually tailored. When ocular metastases are concurrent with widespread metastatic disease, systemic chemotherapy alone or in combination with local therapy is reasonable. In patients manifesting metastases in the eyes alone, local therapy modalities may be safe, allowing conservation of visual functions with minimal systemic morbidity.

Original languageAmerican English
Pages (from-to)372-377
Number of pages6
Issue number6
StatePublished - 2004
Externally publishedYes


  • Brachytherapy
  • Choroidal metastasis
  • Ocular metastasis


Dive into the research topics of 'Treatment options in the management of choroidal metastases'. Together they form a unique fingerprint.

Cite this